đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
The purpose of this observer blind study is to assess the safety in terms o...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-10-22
Trial ID
NCT00547248
Treatments Being Tested
This study will evaluate the immunogenicity of a reduced dosing schedule of...
Status
Completed
Location
Chris Hani Baragwanath Academic Hospital
Start Date
2017-01-09
Trial ID
NCT02943902
Treatments Being Tested
This study will assess the impact on nasopharyngeal carriage, safety and im...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-02-09
Trial ID
NCT01262872
The proposed study is aimed at assessing the safety and immunogenicity of r...
Status
Completed
Location
Site 55 - Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)
Start Date
2011-04
Trial ID
NCT01339923
This PMS study aims to collect safety and reactogenicity data of Synflorixâ˘...
Status
Withdrawn
Location
Multiple Locations
Start Date
2013-04
Trial ID
NCT01803425
Treatments Being Tested
Pneumococcus is a group of bacteria that can cause pneumonia, meningitis an...
Status
Completed
Location
Pasteur Institute of Ho Chi Minh City
Start Date
2013-09-30
Trial ID
NCT01953510
The study aims to evaluate the safety and immunogenicity of the 10-valent a...
Status
Unknown
Location
Papua New Guinea Institute of Medical Research
Start Date
2011-11
Trial ID
NCT01619462
Treatments Being Tested
This study will evaluate safety, reactogenicity and immunogenicity of GSK B...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-08-07
Trial ID
NCT00344318
Treatments Being Tested
The purpose of this phase III study is to demonstrate immunologic non-infer...
Status
Unknown
Location
Multiple Locations
Start Date
2023-08-28
Trial ID
NCT05721456
Treatments Being Tested
The purpose of this study is to provide critical information on the safety,...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-04-08
Trial ID
NCT03636906
Treatments Being Tested